M

Morningside Venture Partners

3 employees

Morningside Venture Partners focuses on partnering with talented entrepreneurs to develop the next wave of truly great companies.

Investor insights

Sectors invested in

Biotechnology8
Medical5
Therapeutics5
Health Care3
Artificial Intelligence3
Lead Nurturing2
Software2
Engagement Marketing2
Demand Generation2
Sales Prospecting2
Machine Learning2
Corporate Gifting2
B2B gifting2
SaaS2
Advertising2
Customer Marketing2
Account Based Marketing2
Life Science2
Internet2
Cancer Immunotherapy1

Funding rounds participated in

$20M sweet spot round size

Most of their 20 investments are in rounds between $3M and $43M

Investor type

Angel Group
Venture Capital

Basic info

Industry

venture capital & private equity

Sectors

Financial Services
Finance
Venture Capital

Date founded

2018

Investments made

O

Otolith Labs raised $20M on September 7, 2022

Investors: Morningside Venture Partners

C

CellCentric raised undisclosed on January 26, 2022

Investors: Morningside Venture Partners

P

Prilenia raised $43M on November 3, 2021

Investors: Sectoral Asset Management, Amplitude Ventures, Sands Capital Management, Forbion, ALS Investment Fund and Morningside Venture Partners

A

Alyce raised $30M on April 8, 2021

Investors: Alumni Ventures Group, General Catalyst, Golden Ventures, Boston Seed Capital, Manifest Investment Partners, LLC, Victress Capital, LLC and Morningside Venture Partners

U

Undisclosed raised $100M on October 28, 2020

Investors: Lilly Asia Ventures, Wellington Management, Temasek, OrbiMed Advisors, Vivo Capital and Morningside Venture Partners

G

GreenLight Biosciences, Inc. raised $102M on June 16, 2020

Investors: Lewis & Clark Ventures, Spruce Capital Partners, LLC, Fall Line Capital, Continental Grain Company, S2G Ventures, Tao Capital Partners and Morningside Venture Partners

A

Alyce raised $12M on June 10, 2019

Investors: Golden Ventures, Alumni Ventures Group, Manifest Investment Partners, LLC, Victress Capital, LLC, Boston Seed Capital, Evolution VC Partners, General Catalyst and Morningside Venture Partners

E

EpiVax Therapeutics, Inc. raised $1.2M on June 12, 2018

Investors: NextWaveBio, Accelerate NY Seed Fund and Morningside Venture Partners

C

CellCentric raised $26M on May 15, 2018

Investors: Morningside Venture Partners

U

Undisclosed raised $18M on April 2, 2018

Investors: 云启资本, Chunxiao Capital and Morningside Venture Partners

FAQ